Novartis Czech Republic made a net profit of CZK 71.0 mil with revenues of CZK 6,312 mil in 2017, down by 6.08% and down by 1.25%, respectively, compared to the previous year.
This translates into a net margin of 1.12%. Historically, between 2000 and 2017, the firm’s net margin reached a high of 1.75% in 2014 and a low of 0.131% in 2000. The average net margin in the last five years amounted to 1.38%.
On the operating level, the EBITDA margin reached 2.18% and EBIT amounted to 1.76% of sales in 2017.
You can see all the company’s data at Novartis Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
